Company intelligence / Profile preview

Prismea

London, England, United Kingdomprismea.com ↗

Ownership: Private
Development stage: Other

Overview

Prismea develops and delivers bioinformatics, image analysis, data management, and sample tracking solutions tailored to the needs of biotech companies. Their flagship product, SampleSafe.app, is a progressive web app that enables lab technicians and clinicians to track samples throughout their lifecycle in the lab. The company focuses on streamlining research workflows with secure, compliant cloud-based tools.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

No major pharmaceutical or biotech partnerships publicly listed; works with various biotechs as clients.

Beyond the preview

Go deeper on Prismea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prismea.

Explore the full profile